Personalized pathway-activated systems imaging in oncology : principal and instrumentation / Tomio Inoue, David Yang, Gang Huang, editors.
Inoue, Tomio, editor.; Yang, David, editor; Huang, Gang, editor.
2017
RC270.3.D53
Available Online

Linked e-resources

Linked Resource Online Access
Concurrent users Unlimited
Authorized users Authorized users
Document Delivery Supplied Can lend chapters, not whole ebooks

Details

Title Personalized pathway-activated systems imaging in oncology : principal and instrumentation / Tomio Inoue, David Yang, Gang Huang, editors.
ISBN 9789811033490 (electronic book)
9811033498 (electronic book)
9789811033483
981103348X
DOI https://doi.org/10.1007/978-981-10-3349-0
Published Singapore : Springer, 2017.
Language English
Description 1 online resource.
Item Number 10.1007/978-981-10-3349-0 doi
Call Number RC270.3.D53
Dewey Decimal Classification 616.99/40754
Summary This comprehensive volume covers radiopharmaceuticals developed for pathway-directed systems in imaging and theranostic applications. We now are at the cutting edge of providing personalized treatment with increased use in oncology of these new radiopharmaceuticals. Trends in high-resolution instrumentation development, quality assurance systems and regulatory compliance for radiopharmaceuticals, clinical evaluation of radiopharmaceuticals, and benefits and pitfalls of the current clinical FDG PET are discussed. Radiopharmaceuticals are used for diagnosis of diseases of the central nervous and cardiovascular systems and for staging, restaging, and treatment planning for cancers. Nuclear biomarkers allow precise measurement of molecular pathways on a whole-body image upon administration of functional radiolabeled agents, and nuclear imaging agents have potential use in patient selection, pharmacokinetic, dosage-finding, and proof-of-concept studies. Nuclear imaging agents and hybrid instrumentation also provide sensitive and specific answers for differential responsiveness in therapeutic outcome. This book serves as a reference for moving the discovery and development of radiopharmaceuticals from the workbench to clinical applications. It thus benefits not only clinicians but also translational research scientistsℓ́ℓmolecular biologists, chemists, imaging scientists, pharmaceutical developers, physicists, and support staff.
Access Note Access limited to authorized users.
Digital File Characteristics text file PDF
Source of Description Online resource; title from PDF title page (SpringerLink, viewed March 8, 2017).
Added Author Inoue, Tomio, editor.
Yang, David, editor
Huang, Gang, editor.
Available in Other Form Print version: 9789811033483
Linked Resources Online Access
Record Appears in Online Resources > Ebooks
All Resources
Part 1: Chemical Biology Aspect
Chapter 1: PET Radiotracers for Tumor Imaging (Ming Rong Zhang)
Chapter 2. Theranostic tracers for pathway-activated systems in oncology (Lan V. Pham, Jerry L. Bryant, David Yang, and Richard J. Ford)
Chapter 3. Optimization of Aseptic Production in PET Radiopharmaceuticals for Compliance to the Most Current GMP (Chih-Hao K. Kao)
Part 2: Engineering and Instrumentation Aspect
Chapter 4. OpenPET enabling PET imaging during radiotherapy (Taiga Yamaya and Hideaki Tashima)
Chapter 5. High Resolution PET/CT development (Wai-Hoi Wong, and Yuxuan Zhang)
Part 3: Social Aspect
Chapter 6. Ethics, Regulations and Clinical Development of Precision Medicine: Activating with molecular imaging (Chieko Kurihara, and Tomio Inoue)
Chapter 7. Optical Imaging: How far can we go (Wenbin Ma, Sara Herrera-Rodriguez, and Hector Martinez-Valdez)
Part 4: Clinic Aspect
Chapter 8. Applications of UIH High Resolution PET/CT in Zhongshan Hospital (Jun Zhou, Hongcheng Shi)
Chapter 9. Clinical evaluation of focused high-resolution breast PET (Kanae Kawai Miyake, Yuji Nakamoto)
Chapter 10. Recent Developments with Large-bore PET/CT (Tomohiro Kaneta, Tomio Inoue)
Chapter 11. Copper-labeled radiopharmaceuticals in oncology (Hiroaki Kurihara)
Chapter 12. PET radiopharmaceuticals in oncology beyond FDG (Shao-Li Song, Pan-Li Li, Gang Huang)
Chapter 13. Molecular Imaging in Oncology: Challenges and Opportunities in 21st Century (Ya-Ming Li, Ya-Ming Li, David J. Yang, and Xue-Na Li)
Chapter 14. Visualization of Apoptosis: Annexin V imaging (Skye Hsin-Hsien Yeh, Fan-Lin Kong, Ming-Hsien Lin).

Browse Subjects

Show more subjects...

Statistics

from
to
Export